Suchergebnisse - "de Marinis, F"

PubPharm (145)

1

SAPPHIRE : phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2024

von Borghaei, H. | de Marinis, F. | Dumoulin, D. | +118

2

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer : results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT)

enthalten in: ESMO open | 2023

von Gridelli, C. | Peters, S. | Velcheti, V. | +2

3

Safety of mRNA-COVID-19 Vaccines in Patients With Thoracic Cancers

enthalten in: Clinical lung cancer | 2023

von Spitaleri, G. | Trillo Aliaga, P. | Catania, C. | +8

4

The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC) : an international Delphi consensus report

enthalten in: ESMO open | 2022

von Hardenberg, M. | Patel, B. | Matthews, C. | +12

5

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Passaro, A. | Leighl, N. | Blackhall, F. | +31

6

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2 : results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology

enthalten in: ESMO open | 2022

von Gridelli, C. | Peters, S. | Mok, T. | +4

7

Anti-TIGIT to overcome resistance to immune checkpoint inhibitors in lung cancer : limits and potentials

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Attili, I. | Passaro, A. | de Marinis, F.

CommentOn: Ann Oncol. 2022 Feb;33(2):169-180. - PMID 34800678

8

Metronomic oral vinorelbine in previously untreated advanced non-small-cell lung cancer patients unfit for platinum-based chemotherapy : results of the randomized phase II Tempo Lung trial

enthalten in: ESMO open | 2021

von Camerini, A. | Morabito, A. | Montanino, A. | +12

9

Lung carcinoids with high proliferative activity : Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Rubino, M. | Scoazec, J. | Pisa, E. | +12

10

Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2020

von Früh, M. | Panje, C. | Reck, M. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]